108 related articles for article (PubMed ID: 2629151)
1. [Urinary enzymes as a marker of the preclinical stage of diabetic nephropathy].
Dedov II; Mukhin NA; Pal'tsev MA; Delektorskaia LN; Shestakova MV
Ter Arkh; 1989; 61(12):73-6. PubMed ID: 2629151
[TBL] [Abstract][Full Text] [Related]
2. [Urinary enzymes in the assessment of the early stage of kidney involvement in psoriasis and diabetes mellitus].
Golov KG; Varshavskiĭ VA; Okunev DIu; Neverov NI; Shestakova MV; Proskurneva FP
Ter Arkh; 1995; 67(10):80-1. PubMed ID: 8779118
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].
Minakami H
Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of beta-thromboglobulin and N-acetyl-beta-D-glucosaminidase in type 1 diabetes: potential indicators of early nephropathy?
Patrick AW; Oliver MD; Howie AF; Dawes J; Macintyre CC; Frier BM
Diabete Metab; 1990; 16(5):441-7. PubMed ID: 2150050
[TBL] [Abstract][Full Text] [Related]
5. [Urine enzymes and low molecular weight proteins as indicators of diabetic nephropathy].
Jung K; Pergande M; Schimke E; Ratzmann KP
Klin Wochenschr; 1989; 67 Suppl 17():27-30. PubMed ID: 2739355
[TBL] [Abstract][Full Text] [Related]
6. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.
Mocan Z; Erem C; Yildirim M; Telatar M; Değer O
Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616
[TBL] [Abstract][Full Text] [Related]
7. The significance of urinary N-acetyl-beta-D-glucosaminidase for predicting early stage diabetic nephropathy.
Kato H; Takashima T; Kishikawa H; Emura S; Ohmori K
Int J Clin Pract; 1997; 51(8):489-90. PubMed ID: 9536599
[TBL] [Abstract][Full Text] [Related]
8. [Excretion of beta-N-acetylglucosaminidase in urine in type I and type II diabetic patients with and without nephropathy].
Werle E; Bostedt A; Fiehn W; Hasslacher C
Wien Klin Wochenschr Suppl; 1991; 189():59-62. PubMed ID: 1962487
[TBL] [Abstract][Full Text] [Related]
9. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic significance of urinary transferrin in diabetic nephropathy.
Kanauchi M; Nishioka H; Hashimoto T; Dohi K
Nihon Jinzo Gakkai Shi; 1995 Nov; 37(11):649-54. PubMed ID: 8583702
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
Katavetin P; Eiam-Ong S; Suwanwalaikorn S
J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of n-acetyl-beta-D-glucosaminidase and retinol binding protein as alternative indicators of nephropathy in patients with type 1 diabetes mellitus.
Salem MA; el-Habashy SA; Saeid OM; el-Tawil MM; Tawfik PH
Pediatr Diabetes; 2002 Mar; 3(1):37-41. PubMed ID: 15016173
[TBL] [Abstract][Full Text] [Related]
13. Tubulopathy with macroalbuminuria due to diabetic nephropathy and primary glomerulonephritis.
Yaqoob M; McClelland P; Patrick AW; Stevenson A; Mason H; Bell GM
Kidney Int Suppl; 1994 Nov; 47():S101-4. PubMed ID: 7869656
[TBL] [Abstract][Full Text] [Related]
14. [Urinary enzymes as markers of functional state of kidneys with diabetic lesions].
Myhal' LIa; Korol' LV; Nikulina HH; Dudar IO; Zheltovs'ka NV
Fiziol Zh (1994); 2006; 52(1):89-93. PubMed ID: 16553303
[TBL] [Abstract][Full Text] [Related]
15. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
16. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients.
Lazarevic G; Antic S; Vlahovic P; Djordjevic V; Zvezdanovic L; Stefanovic V
Ren Fail; 2007; 29(2):199-205. PubMed ID: 17365936
[TBL] [Abstract][Full Text] [Related]
17. Urinary N-acetyl-beta-D-glucosaminidase activity in type I diabetes mellitus.
Mungan N; Yuksel B; Bakman M; Topaloglu AK; Ozer G
Indian Pediatr; 2003 May; 40(5):410-4. PubMed ID: 12768043
[TBL] [Abstract][Full Text] [Related]
18. [Serum N-acetyl-beta-D-glucosaminidase (NAG) activity in patients with diabetes mellitus with reference to diabetic microangiopathy].
Gosiewska A; Kinalska I; Zarzycki W; Górska M; Borejszo I
Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):28-30. PubMed ID: 1409037
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of the aminopeptidase N, N-acetyl-beta-D-glucosaminidase and dipeptidylpeptidase IV in evaluating tubular dysfunction in patients with glomerulopathies.
Mitic B; Lazarevic G; Vlahovic P; Rajic M; Stefanovic V
Ren Fail; 2008; 30(9):896-903. PubMed ID: 18925530
[TBL] [Abstract][Full Text] [Related]
20. Structural involvement in type 1 and type 2 diabetic nephropathy.
Dalla Vestra M; Saller A; Bortoloso E; Mauer M; Fioretto P
Diabetes Metab; 2000 Jul; 26 Suppl 4():8-14. PubMed ID: 10922968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
